Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: Stepper who wrote (2069)	7/29/1998 7:26:00 PM
From: Tom R. Jones	Read Replies (1) \| Respond to of 2395

Stepper, I would strongly recommend that you go to the FDA site and read the information on BICO's last big FDA meeting. The information clearly indicates that the Diasensor did not have ANY real degree of reliability. After you read that info, call the company and ask what improvements were made to the Diasensor after that FDA meeting. Also, ask about the calibration process. I don't think that FDA approval is all that important right now. If the machine has been improved and is viable, sales in Europe should reflect the Diasensor's REAL value. Even with FDA approval, BICO has to sell the units and assuming they can do that, there is still the problem of up to 600 million shares of stock! Regards, Tom